Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indication

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA17 hours ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA17 hours ago 0

New data, nuances in managing resistant gram-negative infections

DRRA18 hours ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA19 hours ago 0